World Medical Association Declaration of Helsinki by unknown
Adopted by the 18th WMA General Assembly Helsinki,
Finland, June 1964 and amended by the 29th WMA Ge-
neral Assembly, Tokyo, Japan, October 1975, 35th WMA
General Assembly, Venice, Italy, October 1983, 41st
WMA General Assembly, Hong Kong, September 1989,
48th WMA General Assembly, Somerset West, Republic
of South Africa, October 1996 and the 52nd WMA Gene-
ral Assembly, Edinburgh, Scotland, October 2000
A. Introduction
1. The World Medical Association has developed the
Declaration of Helsinki as a statement of ethical
principles to provide guidance to physicians and
other participants in medical research involving hu-
man subjects. Medical research involving human
subjects includes research on identifiable human ma-
terial or identifiable data.
2. It is the duty of the physician to promote and safegu-
ard the health of the people. The physician's know-
ledge and conscience are dedicated to the fulfill-
ment of this duty.
3. The Declaration of Geneva of the World Medical
Association binds the physician with the words, „The
health of my patient will be my first consideration,”
and the International Code of Medical Ethics decla-
res that, „A physician shall act only in the pa-
tient's interest when providing medical care which
might have the effect of weakening the physical and
mental condition of the patient.”
4. Medical progress is based on research which ulti-
mately must rest in part on experimentation invo-
lving human subjects.
5. In medical research on human subjects, considera-
tions related to the well-being of the human subject
should take precedence over the interests of science
and society.
6. The primary purpose of medical research involving
human subjects is to improve prophylactic, diagnostic
and therapeutic procedures and the understanding of
the aetiology and pathogenesis of disease. Even the
best proven prophylactic, diagnostic, and therapeutic
methods must continuously be challenged through
research for their effectiveness, efficiency, accessibi-
lity and quality.
7. In current medical practice and in medical research,
most prophylactic, diagnostic and therapeutic proce-
dures involve risks and burdens.
8. Medical research is subject to ethical standards that
promote respect for all human beings and protect
their health and rights. Some research populations
are vulnerable and need special protection. The par-
ticular needs of the economically and medically disa-
dvantaged must be recognized. Special attention is
also required for those who cannot give or refuse
consent for themselves, for those who may be sub-
ject to giving consent under duress, for those who
will not benefit personally from the research and
for those for whom the research is combined with
care.
9. Research Investigators should be aware of the ethi-
cal, legal and regulatory requirements for research
on human subjects in their own countries as well
as applicable international requirements. No na-
tional ethical, legal or regulatory requirement sho-
uld be allowed to reduce or eliminate any of the
protections for human subjects set forth in this Dec-
laration.
B. Basic principles for all medical research
10. It is the duty of the physician in medical research to
protect the life, health, privacy, and dignity of the
human subject.
11. Medical research involving human subjects must
conform to generally accepted scientific principles,
be based on a thorough knowledge of the scientific
literature, other relevant sources of information, and
on adequate laboratory and, where appropriate, ani-
mal experimentation.
12. Appropriate caution must be exercised in the con-
duct of research which may affect the environment,
and the welfare of animals used for research must be
respected.
13. The design and performance of each experimental
procedure involving human subjects should be clear-
ly formulated in an experimental protocol. This pro-
tocol should be submitted for consideration, com-
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ment, guidance, and where appropriate, approval to
a specially appointed ethical review committee, which
must be independent of the investigator, the sponsor
or any other kind of undue influence. This indepen-
dent committee should be in conformity with the
laws and regulations of the country in which the rese-
arch experiment is performed. The committee has
the right to monitor ongoing trials. The researcher
has the obligation to provide monitoring informa-
tion to the committee, especially any serious adverse
events. The researcher should also submit to the
committee, for review, information regarding fun-
ding, sponsors, institutional affiliations, other poten-
tial conflicts of interest and incentives for subjects.
14. The research protocol should always contain a state-
ment of the ethical considerations involved and sho-
uld indicate that there is compliance with the princi-
ples enunciated in this Declaration.
15. Medical research involving human subjects should be
conducted only by scientifically qualified persons
and under the supervision of a clinically competent
medical person. The responsibility for the human
subject must always rest with a medically qualified
person and never rest on the subject of the research,
even though the subject has given consent.
16. Every medical research project involving human sub-
jects should be preceded by careful assessment of
predictable risks and burdens in comparison with
foreseeable benefits to the subject or to others. This
does not preclude the participation of healthy vo-
lunteers in medical research. The design of all stu-
dies should be publicly available.
17. Physicians should abstain from engaging in research
projects involving human subjects unless they are
confident that the risks involved have been adequate-
ly assessed and can be satisfactorily managed. Physi-
cians should cease any investigation if the risks are
found to outweigh the potential benefits or if there is
conclusive proof of positive and beneficial results.
18. Medical research involving human subjects should
only be conducted if the importance of the objective
outweighs the inherent risks and burdens to the sub-
ject. This is especially important when the human
subjects are healthy volunteers.
19. Medical research is only justified if there is a reaso-
nable likelihood that the populations in which the re-
search is carried out stand to benefit from the re-
sults of the research.
20. The subjects must be volunteers and informed parti-
cipants in the research project.
21. The right of research subjects to safeguard their inte-
grity must always be respected. Every precaution
should be taken to respect the privacy of the sub-
ject, the confidentiality of the patient's information
and to minimize the impact of the study on the sub-
ject's physical and mental integrity and on the perso-
nality of the subject.
22. In any research on human beings, each potential
subject must be adequately informed of the aims,
methods, sources of funding, any possible conflicts of
interest, institutional affiliations of the researcher,
the anticipated benefits and potential risks of the
study and the discomfort it may entail. The subject
should be informed of the right to abstain from par-
ticipation in the study or to withdraw consent to par-
ticipate at any time without reprisal. After ensuring
that the subject has understood the information, the
physician should then obtain the subject's freely-gi-
ven informed consent, preferably in writing. If the
consent cannot be obtained in writing, the non-writ-
ten consent must be formally documented and wit-
nessed.
23. When obtaining informed consent for the research
project the physician should be particularly cautious
if the subject is in a dependent relationship with the
physician or may consent under duress. In that case
the informed consent should be obtained by a well-
-informed physician who is not engaged in the inve-
stigation an who is completely independent of this
relationship.
24. For a research subject who is legally incompetent,
physically or mentally incapable of giving consent
or is a legally incompetent minor, the investigator
must obtain informed consent from the legally au-
thorized representative in accordance with applicable
law. These groups should not be included in rese-
arch unless the research is necessary to promote the
health of the population represented and this rese-
arch cannot instead be performed on legally com-
petent persons.
25. When a subject deemed legally incompetent, such
as a minor child, is able to give assent to decisions
about participation in research, the investigator must
obtain that assent in addition to the consent of the
legally authorized representative.
26. Research on individuals from whom it is not possible
to obtain consent, including proxy or advance con-
sent, should be done only if the physical/mental con-
dition that prevents obtaining informed consent is
a necessary characteristic of the research popula-
tion. The specific reasons for involving research sub-
jects with a condition that renders them unable to gi-
ve informed consent should be stated in the experi-
mental protocol for consideration and approval of
the review committee. The protocol should state that
consent to remain in the research should be obtained
as soon as possible from the individual or a legally
authorized surrogate.
27. Both authors and publishers have ethical obligations.
In publication of the results of research, the inve-
stigators are obliged to preserve the accuracy of the
results. Negative as well as positive results should
be published or otherwise publicly available. Sources
of funding, institutional affiliations and any possi-
ble conflicts of interest should be declared in the
publication. Reports of experimentation not in accor-
dance with the principles laid down in this Declara-
tion should not be accepted for publication.
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C. Additional principles for medical research combined
with medical care
28. The physician may combine medical research with
medical care, only to the extent that the research is
justified by its potential prophylactic, diagnostic or
therapeutic value. When medical research is com-
bined with medical care, additional standards apply
to protect the patients who are research subjects.
29. The benefits, risks, burdens and effectiveness of
a new method should be tested against those of the
best current prophylactic, diagnostic, and therapeu-
tic methods. This does not exclude the use of place-
bo, or no treatment, in studies where no proven pro-
phylactic, diagnostic or therapeutic method exists.
30. At the conclusion of the study, every patient entered
into the study should be assured of access to the best
proven prophylactic, diagnostic and therapeutic me-
thods identified by the study.
31. The physician should fully inform the patient which
aspects of the care are related to the research. The
refusal of a patient to participate in a study must
never interfere with the patient physician relation-
ship.
32. In the treatment of a patient, where proven prophy-
lactic, diagnostic and therapeutic methods do not
exist or have been ineffective, the physician, with in-
formed consent from the patient, must be free to
use unproven or new prophylactic, diagnostic and
therapeutic measures, if in the physician's judgement
it offers hope of saving life, re-establishing health
or alleviating suffering. Where possible, these measu-
res should be made the object of research, designed
to evaluate their safety and efficacy. In all cases, new
information should be recorded and, where appro-
priate, published. The other relevant guidelines of
this Declaration should be followed.
